1. Home
  2. Conferences
  3. Biocides Europe 2025
  4. programme

Agenda

  1. Coffee

  2. Welcome and introduction by the moderator

    David Dillon David Dillon
    Independent Biocides Expert
  3. Session 4: The BPR and national biocides laws

  4. Italian biocides laws and fees

    • Italian law
    • Transitional period 
    • Fees for biocide authorisation 
    Raffaella Perrone Raffaella Perrone
    Director, Office of Biocides and Cosmetics Unit, Ministry of Health, Italy

  5. Dutch perspective on developments for harmonisation within authorisation and mutual recognition under the BPR

    • Dutch approach to following the EU framework and limiting national measures   
    • Difference between national-specific elements and ‘country-specific designed SPC’   
    • Current issues regarding mutual recognition and national elements 
    Maarten Klunder Maarten Klunder
    Team Lead Biocides Expertise, Dutch Board for the Authorisation of Plant Protection Products and Biocides, ctgb

  6. GB BPR developments

    • Making sure you handle the transition from the EU BPR correctly
    • Forthcoming changes to the GB biocides regime
    • Compliance strategies across the GB and EU divide 
    Darren Abrahams Darren Abrahams
    Partner, Barrister & Avocat, Steptoe International (UK) LLP

  7. How to navigate the patchwork of different national rules, tips and tricks

    • How to make sure local registrations are in place before the BPR deadline
    • Renewal and updates after the BPR submission
    Carine Suurmeijer Carine Suurmeijer
    Senior Regulatory Specialist, Diversey, a Solenis company

  8. Q&A 

  9. Refreshment break and networking

  10. Finding the right balance: Prevention of greenwashing v meaningful promotion of biocides

    Peter Kugel Peter Kugel
    Partner, VVGB Advocaten/Avocats, Belgium

  11. Q&A and panel discussion: Harmonisation under the BPR and interplay with member state procedures and capacitites

    • Funding of member state competent authorities
    • Workable processes
    • Harmonisation developments: Authorisation under articles 19.1 and 19.5 and mutual recognition   

  12. Lunch and networking

  13. Session 5: Latest experiences with endocrine disruption (ED) assessment

  14. Regulatory update for ED evaluation

    • Regulatory requirements according to BPR
    • Following the ECHA /EFSA guidance
    • Gathering of data
    • What companies need to deliver and how
    • Challenges with the new CLP hazard class for ED and the new one substance, one assessment (OSOA) concept 
    Maristella Rubbiani Maristella Rubbiani
    Senior Advisor, Rud Pedersen Public Affairs

  15. ED testing at a crossroads: Four cases, one urgent deadline with practical solutions

    • Overview of the ED data requests received with December 2026 deadline
    • Case study insights - anonymized examples highlight the commercial, ethical and regulatory impacts of the ED study requests
    • Expected, intended and unforeseen effects
    • Potential pragmatic solutions
    Samantha Walker Samantha Walker
    Head of Biocides & Cosmetics, Sagentia Regulatory, formerly TSG Consulting

  16. High stakes learning-by-doing – challenges with the aquatic ED studies under the BPR

    • Role of guideline non-target organism studies in ED assessment 
    • Inconsistencies in information these studies provide v regulatory requirements and expectations
    • Challenges faced in timelines, acceptance and interpretation of studies, and their consequences 
    Katherine Clark Katherine Clark
    Team Lead, Toxicology and Environmental Science, Arxada

  17. Q&A

  18. Refreshment break and networking

  19. Session 6: Important efficacy updates

  20. The road from regulation to claims: The efficacy journey and its challenges

    • Impacts of recent updates in the BPR Efficacy Guidances
    • How this affects the product claims for ongoing applications and planned submissions 
    Henry von Rège Henry von Rège
    Senior Managing Consultant and Team Lead Efficacy/Biocides, Ramboll Germany

  21. Efficacy evaluation of algicides

    • Efficacy testing from a laboratory’s perspective
    • Case studies on PT2 and PT11
    • How to proceed when technical guidance is limited 
    Elena Perabo Elena Perabo
    Study Director Ecotoxicology, Hydrotox – Labor für Ökotoxikologie und Gewässerschutz GmbH

  22. Q&A

  23. End of conference

View previous day

/ next day
Back to top